Ontology highlight
ABSTRACT:
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Colon
DISEASE(S): Colon Cancer
SUBMITTER:
Courcelles Mathieu
LAB HEAD: Pierre Thibault
PROVIDER: PXD071022 | Pride | 2026-05-26
REPOSITORIES: Pride
| Action | DRS | |||
|---|---|---|---|---|
| 1055698F_1_mtechuman_3__PP854__JJ_uploaded_file_id_1811.fasta | Fasta | |||
| 1055698F_CRC_200323_1.mgf | Mgf | |||
| 1055698F_CRC_200323_1.raw | Raw | |||
| 1055698F_CRC_200323_2.mgf | Mgf | |||
| 1055698F_CRC_200323_2.raw | Raw |
Items per page: 1 - 5 of 157 |

Molecular & cellular proteomics : MCP 20260507
Treatment with immune checkpoint inhibitors in colorectal cancer (CRC) has largely benefited patients with microsatellite instability-high (MSI-H) and not the larger proportion of patient with microsatellite-stable (MSS) tumors. This clinical dichotomy has fueled the view that high mutational burden is the dominant driver of tumor immunogenicity and that MSS CRC fails to respond because it is "antigen poor". To directly test this premise and define the origins of presented tumor antigens, we int ...[more]